Cafepharma Today

April 2 2020 - COVID-19 threatens M&A already in process
COVID-19 threatens M&A already in process
Physician survey shows widespread concern about access to testing and medical supplies for COVID
Novartis cancels $1B generics sale
Flagship raises $1.1B to create biotechs for post-pandemic world
*please scroll down for all the latest news*

Stay updated with the latest pharma-related coronavirus news on our new page

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19
Motley Fool
Friday, April 3, 2020 - 12:02am
tags:
cancer, COVID-19, Incyte, Jakafi
Boston Scientific Cuts Pay and Withdraws Revenue Guidance
Medical Devices and Diagnostics Industry
Friday, April 3, 2020 - 12:00am
tags:
Boston Scientific, devices, executive pay, COVID-19
Merck scores new advance on tumor-agnostic front as Keytruda beat chemo-based regimens in a type of colorectal cancer
Endpoints
Thursday, April 2, 2020 - 11:59pm
tags:
Merck, Keytruda, colorectal cancer
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Fierce Pharma
Thursday, April 2, 2020 - 11:58pm
tags:
Biocon, insulin, diabetes, Lantus, Mylan, drug manufacturing
COVID-19 vaccine packed into skin patch shows promise in mice
Fierce Biotech
Thursday, April 2, 2020 - 11:57pm
tags:
COVID-19, vaccines, vaccine patches
FDA: You Can Use Chloroquine to Treat COVID-19; EU Regulators: Not Just Yet
Motley Fool
Thursday, April 2, 2020 - 11:55pm
tags:
chloroquine, hydroxychloroquine, FDA, Europe, COVID-19
Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic
Motley Fool
Thursday, April 2, 2020 - 11:54pm
tags:
physicians, COVID-19, Pfizer, Merck, Eli Lilly
A Covid-19 threat to business acquisitions
EP Vantage
Thursday, April 2, 2020 - 11:57am
tags:
COVID-19, M&A, AbbVie, Allergan, Arya Sciences, Immatics, AcelRx, Tetraphase, Gilead Sciences, Forty Seven, Thermo Fisher, Stryker, Wright Medical
There's a New 15-Minute Coronavirus Test
Motley Fool
Thursday, April 2, 2020 - 11:05am
tags:
Becton Dickinson, BioMedomics, coronaviruses, COVID-19, diagnostics
Why Biogen Shares Rose 2.59% in March
Motley Fool
Thursday, April 2, 2020 - 11:03am
tags:
Biogen, COVID-19
Akero’s success gives a new Nash mechanism hope
EP Vantage
Thursday, April 2, 2020 - 11:01am
tags:
Akero Therapeutics, NASH, AKR-001
Physician surveys show widespread concern about access to testing, medical supplies
MedCity News
Thursday, April 2, 2020 - 11:00am
tags:
physicians, pandemic, COVID-19, diagnostics, medical supplies
Amgen teams up with Adaptive to both treat and prevent COVID-19
Fierce Biotech
Thursday, April 2, 2020 - 10:56am
tags:
Amgen, Adaptive Biotechnologies, R&D, COVID-19
AI and cancer care: 3 ways artificial intelligence may transform cancer outcomes
Pharmaforum
Thursday, April 2, 2020 - 10:51am
tags:
artificial intelligence, machine learning, cancer, oncology, imaging, liquid biopsies
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Thursday, April 2, 2020 - 10:49am
tags:
Novartis, generics, Sandoz, antitrust
Giuliani-promoted COVID-19 therapy from Celularity nabs FDA speedy trial start
Fierce Biotech
Thursday, April 2, 2020 - 10:47am
tags:
Celularity, Donald Trump, Rudy Giuliani, FDA, COVID-19, CYNK-001
Flagship raises $1.1B to create biotechs for post-pandemic world
Fierce Biotech
Thursday, April 2, 2020 - 10:45am
tags:
Flagship Pioneering, biotech, COVID-19, pandemic
Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial
Pharmaforum
Thursday, April 2, 2020 - 10:44am
tags:
Mallinckrodt, Novoteris, Health Canada, clinical trials, nitric oxide, COVID-19, Thiolanox, devices, ARDA
Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19
Pharmaceutical Business Review
Thursday, April 2, 2020 - 10:40am
tags:
Citius Pharmaceuticals, Novelius, stem cells, ARDS, COVID-19
Zantac, generics ordered off the market after FDA finds they're a ticking time bomb
Fierce Pharma
Thursday, April 2, 2020 - 12:03am
tags:
FDA, Zantac, carcinogens, ranitidine

Pages

Latest CP Wire Articles

Whistleblowing in the Time of COVID-19
RAPT Therapeutics Files for $100 Million Offering
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
Can You Get Cancer From Zantac? [sponsored]
Seelos Therapeutics Files Paperwork for $14 Million Offering
ADiTxT Therapeutics Files for $25 Million IPO
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
PPD Files the Paperwork for $100 Million IPO
Mirum Pharmaceuticals Files for $63 Million Offering
Arcutis Biotherapeutics Files for $100 Million IPO

Latest Pharmagather Articles

Creating a Digital Solution Patients and HCPs Will Use
pharmexec technology
Covid-19, Blood Pressure Medication, and Ibuprofen
In the Pipeline
Impact of COVID-19 on Regulatory Enforcement and Approvals – Part 3 – FDA Adds Resources to Facilitate COVID-19 Research
eye on fda
Protected: Analgesics Use and the Coronavirus: Finding Answers Through Biological Knowledge Graph
Elsevier
Comparing HydroxyChloroquine Trials
In the Pipeline
Drug Channels News Roundup, March 2020: Sanofi’s Gross-to-Net Bubble, Drug Pricing Findings, Amazon Replaces Express Scripts, and Drug Channels Video
Drug Channels
Huge COVID-19 Emergency Bill Bolsters FDA, Healthcare Coverage
pharmexec r&d
More on Chloroquine/Azithromycin. And On Dr. Raoult.
In the Pipeline
Are Field Sales Reps Getting a Bad Deal With Data?
pharmexec marketing

Pharma and Device News from NASDAQ

Gevo Hires Citigroup to Assist with Financings
Thursday, April 2, 2020 - 9:00am
CurvaFix Announces the Appointment of Two New Board Members
Thursday, April 2, 2020 - 9:00am
Trxade Spotlighted in Publication Discussing Healthcare Challenge, Solution
Thursday, April 2, 2020 - 8:30am
MATEON THERAPEUTICS TEAM PUBLISHES A NEW PEER-REVIEWED ONCOLOGY ARTICLE ON THE POSITIVE CLINICAL STUDY RESULTS FOR OT-101 AGAINST RECALCITRANT RESISTANT ANAPLASTIC ASTROCYTOMA – A RARE FORM OF MALIGNANT BRAIN TUMOR
Thursday, April 2, 2020 - 8:00am
Geron Provides COVID-19 Related Business Update
Thursday, April 2, 2020 - 8:00am
RAPID DOSE THERAPEUTICS DONATES QUICKSTRIP™ VITAMIN B12 NUTRACEUTICAL PRODUCT TO COMMUNITY
Thursday, April 2, 2020 - 8:00am
Treatment with CytoDyn's Leronlimab Indicates Significant Trend Toward Immunological Restoration in Severely Ill COVID-19 Patients
Thursday, April 2, 2020 - 6:00am
Small NJ Biotech Firm, BioAegis Therapeutics, Accelerating Multiple Clinical Trial Submissions for Severe COVID-19 Pneumonia Patients
Thursday, April 2, 2020 - 2:15am
Heart Health Intelligence Raises Funds for a Revolutionary In-Home Cardiovascular Monitoring Device
Wednesday, April 1, 2020 - 11:00am
BOQI International Medical Announces Stock Purchase Agreement to Spin Off its Energy Business
Wednesday, April 1, 2020 - 8:30am

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information